Avient EPS AVNT
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $1.85
- Latest quarter, Q2 FY26
- $0.70
- +23% on a year earlier
- Fiscal year 2025
- $0.89
- −52% on the year before
Avient's earnings per share was $1.85 over the twelve months to Jun 30, 2026, up 43% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.70, up 23% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 9% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.89 | −52% |
| FY2024 | $1.84 | +122% |
| FY2023 | $0.83 | −89% |
| FY2022 | $7.59 | +205% |
| FY2021 | $2.49 | +71% |
| FY2020 | $1.46 | −81% |
| FY2019 | $7.59 | +285% |
| FY2018 | $1.97 | n/a |
| FY2017 | −$0.69 | −135% |
| FY2016 | $1.95 | +20% |
| FY2015 | $1.62 | +93% |
| FY2014 | $0.84 | −66% |
| FY2013 | $2.48 | +214% |
| FY2012 | $0.79 | −56% |
| FY2011 | $1.80 | +7% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.70 | +23% | $1.85 | |
| Q1 FY26 | $0.61 | n/a | $1.72 | |
| Q4 FY25 | $0.18 | −66% | $0.89 | |
| Q3 FY25 | $0.36 | −12% | $1.24 | |
| Q2 FY25 | $0.57 | +58% | $1.29 | |
| Q1 FY25 | −$0.22 | −141% | $1.08 | |
| Q4 FY24 | $0.53 | +71% | $1.84 | |
| Q3 FY24 | $0.41 | +583% | $1.62 | |
| Q2 FY24 | $0.36 | +50% | $1.27 | |
| Q1 FY24 | $0.54 | +145% | $1.15 | |
| Q4 FY23 | $0.31 | −95% | $0.83 | |
| Q3 FY23 | $0.06 | n/a | $6.39 |
Against its peers
Companies in Chemicals nearest Avient's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| AVNTAvient | $1.85 | +43% a year |
| CBTCabot | $3.54 | −54% a year |
| CSWCSW Industrials | $7.29 | −13% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| FULFuller H B | $3.59 | +72% a year |
| BCPCBalchem | $5.09 | +16% a year |
| IOSPInnospec | $4.90 | +545% a year |
| NGVTIngevity | $1.47 | |
| HXLHexcel | $1.99 | +84% a year |
| ROGRogers | $1.75 | |
| EMNEastman Chemical | $3.84 | −46% a year |
| Peer median | $3.71 |
Where Avient ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Avient
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.